Loading...
  • patients
  • The bone agent, F-18-fluoride and the tumour agent F-18-fluorodeoxyglucose, have been used to evaluate both benign and malignant skeletal disorders qualitatively and quantitatively and the current knowledge with respect to the skeleton in cancer patients is summarised in this article. (icr.ac.uk)
  • images
  • Figure 1: F18-FDG PET images using standard voxel reconstruction (A) and small voxel reconstruction (B). The lesion in the left lung (volume 0.68 mL) with a SUVmax of 2.6 using the standard voxel reconstruction, increased by 54% to 4.0 using the small voxel reconstruction. (philips.sk)
  • Figure 2: F18-FDG Pet images with standard voxel reconstruction (A) and small voxel reconstruction (B). The SUVmax of the lesion in the right hilar region (volume 0.50 mL) with a SUVmax of 3.0 using the standard voxel reconstruction, increased by 45% to 4.4 on the small voxel reconstruction (black arrow). (philips.sk)
  • PET/CT with F-18-fluorodeoxyglucose (FDG) images of patients suffering from metastatic melanoma have been analysed using fractal and multifractal analysis to assess the impact of monoclonal antibody ipilimumab treatment with respect to therapy outcome. (grnet.gr)